Medication
Ramipril
DIN 02255316 · Laboratoire Riva Inc. Likely a generic
What it is
- Active ingredients
- Ramipril — 2.5 mg
- Form and route
- Capsule · Oral
- Schedule
- PRESCRIPTION
- Authorised since
- 2008-03-14
Source: Health Canada — Drug Product Database. Data current as of 2026-08-12.
Products with the same active ingredient
- Altace
- Teva-Ramipril
- Apo-Ramipril
- Ramipril
- Pro-Ramipril - 2.5
- Taro-Ramipril
- Jamp-Ramipril
- Auro-Ramipril
- Mar-Ramipril
- Mint-Ramipril
- Pharma-Ramipril
- AG-Ramipril
- Nra-Ramipril
- PMSC-Ramipril
Grouped by Health Canada’s active-ingredient group number. Products in a group do not always share a strength — check the strength above against your own. Sharing an active ingredient does not mean two products can be substituted for each other: whether a substitution is permitted is a provincial decision, and this page does not show it. Ask a pharmacist.
Watch this medication
Ontario Drug Benefit coverage
As of 31 July 2026Listed, not a benefit Part III
This product appears in Ontario’s Formulary/CDI but is not an ODB benefit — Ontario does not pay for it. It is listed so that a pharmacist can see which products are interchangeable with it, which is usually the case for an originator brand sitting beside its generics.
Source: Ontario Ministry of Health — ODB Formulary. Data current as of 2026-07-28. Ontario only. Formulary edition 4342, effective 31 July 2026.
Products Ontario considers interchangeable
As of 31 July 2026Ontario groups these products together at 2.5mg and will substitute one for another at a pharmacy counter in Ontario.
- AG-Ramipril 02477572Angita Pharma Inc.
- Altace 02221837Bausch Health Canada Inc.
- Apo-Ramipril 02251531Apotex Inc
- Auro-Ramipril 02387395Auro Pharma Inc
- Jamp-Ramipril 02331128Jamp Pharma Corporation
- Mar-Ramipril 02420465Marcan Pharmaceuticals Inc
- Mint-Ramipril 02421305Mint Pharmaceuticals Inc
- Nra-Ramipril 02486172Nora Pharma Inc
- Pharma-Ramipril 02469065Pharmascience Inc
- PMSC-Ramipril 02550210Pharmascience Inc
- Ramipril 02287927Sivem Pharmaceuticals ULC
- Taro-Ramipril 02310511Sun Pharma Canada Inc
- Teva-Ramipril 02247945Teva Canada Limited
Ontario lists 3 further products in this group that are not currently marketed in Canada. They are not shown.
This is Ontario’s designation, under the Ontario Drug Benefit program, and it applies in Ontario. It is a different statement from the same-active-ingredient list above, which is Health Canada’s grouping and carries no substitution meaning at all. No other province’s rules are shown on this page, and a designation here is not a recommendation to switch — that is a conversation with a pharmacist or prescriber.
Source: Ontario Ministry of Health — ODB Formulary. Data current as of 2026-07-28. Ontario only. Formulary edition 4342, effective 31 July 2026.
How it is classified
- Anatomical main group
- Cardiovascular system
- ATC code
- C09AA05
The Anatomical Therapeutic Chemical code records the body system a medicine acts on and its chemical grouping. It is not a statement of what this medication treats, and nothing on this page is. For the full classification of C09AA05, see the WHO ATC/DDD Index.
Recalls and safety alerts
As of 12 August 2026Possible matches
These notices name a product name that more than one company sells. They may or may not concern this manufacturer’s product — Health Canada’s data does not say. They are not recalls of this product.
Possible match. This notice names “RAMIPRIL”, and 7 authorised products from 2 companies are sold under that name. The notice does not say which of them is affected.
This list may be incomplete. Health Canada’s recalls data carries no DIN, so notices are matched on wording alone. Search Health Canada recalls for Ramipril → How RxMonitor matches recalls, and how often it fails
Source: Health Canada — Recalls and Safety Alerts. Data current as of 2026-08-12. Matched on product name, not on DIN — the feed carries none.